IRIS UniCatt

Forgione, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.567
AS - Asia 1.367
EU - Europa 1.343
SA - Sud America 236
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 4.554
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.523
SG - Singapore 611
DE - Germania 561
CN - Cina 384
BR - Brasile 196
SE - Svezia 195
FR - Francia 128
VN - Vietnam 93
UA - Ucraina 89
IE - Irlanda 76
IT - Italia 72
GB - Regno Unito 64
JP - Giappone 48
FI - Finlandia 46
ID - Indonesia 42
IN - India 37
TR - Turchia 36
RU - Federazione Russa 29
AR - Argentina 27
BD - Bangladesh 25
KR - Corea 19
PL - Polonia 19
CA - Canada 17
BE - Belgio 16
HK - Hong Kong 14
MX - Messico 12
IQ - Iraq 11
NL - Olanda 10
ZA - Sudafrica 10
CH - Svizzera 8
IR - Iran 8
AT - Austria 7
PK - Pakistan 6
DZ - Algeria 4
EG - Egitto 4
ES - Italia 4
JM - Giamaica 4
MA - Marocco 4
PH - Filippine 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CO - Colombia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
EU - Europa 3
IL - Israele 3
KE - Kenya 3
MD - Moldavia 3
TN - Tunisia 3
BZ - Belize 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
GE - Georgia 2
HR - Croazia 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RE - Reunion 2
SV - El Salvador 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TW - Taiwan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.554
Salva come PNG Salva come JPEG
Città #
Singapore 315
Chandler 181
Ashburn 173
San Jose 156
Dublin 76
Hefei 71
Chicago 65
Beijing 58
Jacksonville 51
Tukwila 48
San Mateo 47
Tokyo 47
Lauterbourg 45
Los Angeles 44
Jakarta 41
Ann Arbor 40
Marseille 39
Nanjing 38
Ho Chi Minh City 34
Nürnberg 34
New York 32
Munich 30
Frankfurt am Main 28
Milan 27
Helsinki 25
Izmir 25
Hanoi 22
Boston 21
Woodbridge 21
Dallas 19
Kent 19
Moscow 19
Dearborn 18
Seoul 18
Wilmington 18
Houston 17
Princeton 17
Brussels 15
Boardman 14
Kraków 13
Hong Kong 12
São Paulo 12
Santa Clara 11
Düsseldorf 10
Bremen 9
Nanchang 9
Nuremberg 9
Shanghai 9
Shenyang 9
Brasília 8
Redwood City 8
The Dalles 8
Buffalo 7
Manaus 7
Orem 7
Phoenix 7
Poplar 7
Provo 7
Zhengzhou 7
Brooklyn 6
Cape Town 6
Fremont 6
Paris 6
Rome 6
Toronto 6
Utrecht 6
Zurich 6
Baghdad 5
Jiaxing 5
Jinan 5
Kunming 5
Las Vegas 5
Leawood 5
Pune 5
San Francisco 5
Stockholm 5
Tabriz 5
Ankara 4
Boydton 4
Charlotte 4
Denver 4
Guangzhou 4
Guarulhos 4
Hangzhou 4
Hebei 4
Montreal 4
Salvador 4
Tianjin 4
Turku 4
Vienna 4
Warsaw 4
Atlanta 3
Baku 3
Bexley 3
Brno 3
Buenos Aires 3
Cattolica 3
Changsha 3
Chennai 3
Dhaka 3
Totale 2.365
Salva come PNG Salva come JPEG
Nome #
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 247
-Hepatic steatosis and vascular disease 236
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 214
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 200
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 190
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 175
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 174
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 170
-Fatty liver and drugs 161
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 161
gastroesophageal reflux disease: facts and uncertaines 154
Tromboembolism and breast cancer: the hidden risk for patient and physician 145
-Nonalcoholic fatty liver disease: defining a common problem 139
Alcoholic and nonalcoholic forms of fatty liver disease. 129
Pattern of macrovascular invasion in hepatocellular carcinoma 120
Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test. 119
anticholinergic syndrome due to " Devil's herb': when risks come from the ancient time 100
Monofocal hepatocellular carcinoma: How much does size matter? 98
-The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. 96
PREVALENCE OF LIVER STEATOSIS AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 94
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. 88
Body composition and nutrient utilisation in patients with non-alcoholic steato-hepatitis (NASH) 86
Genetic and environmental factors responsible for oxidative stress in now alcoholic fatty liver disease (NAFLD) 85
Anticholinergic syndrome due to 'Devil's herb': when risks come from the ancient time 85
SERUM SODIUM IS A PREDICTOR OF SURVIVAL FOR "INTERMEDIATE HCC" TREATED WITH TRANSARTERIAL CHEMIOEMBOLIZATION (TACE) 81
Use of G-CSF during acute on chronic liver failure: Clinical and biochemical safety profile 79
A PROPOSAL MODEL FOR THE NON-INVASIVE ASSESSMENT OF HISTOLOGICAL INFLAMMATION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) 78
PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS 78
Mild hepatitis at recommended doses of acetaminophen in patients with evidence of constitutionally enhanced cytochrome P450 system activity 77
Intestinal permeability in nonalcoholic fatty liver disease (NAFLD) 73
CXCR4, vegfr and VLA-4 levels in peripheral blood lymphocytes of patients with acute on chronic liver failure treated with G-CSF 72
G) Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test 68
Thromboembolism and breast cancer: the hidden risk for patient and physician 67
Eighteen needles to forget...an unnamed past 65
Fibrogenesis and fibrosis in nonalcoholic steatohepatitis 64
Serum levels of metalloproteinases and their inhibitors in nonalcoholic steatohepatitis 61
Quantitative liver function tests to assess MEHOS activity in NASH patients 60
FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA 59
C-Methacetin breath test in patients with nonalcoholic steatohepatitis after hypocaloric diet therapy 55
Serum markers of fibrogenesis and fibrosis in nonalcoholic steatohepatitis (NASH) 50
Nonalcoholic-Steatohepatitis (NASH) and hepatic mitochondrial beta-oxidation 47
Totale 4.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.059
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022199 4 29 6 23 11 4 2 35 3 14 32 36
2022/2023629 53 65 30 81 58 80 53 43 73 51 32 10
2023/2024329 25 118 4 15 28 31 11 4 0 24 36 33
2024/2025710 11 17 66 8 65 23 17 41 107 59 165 131
2025/20261.676 281 71 111 167 281 83 247 82 113 114 73 53
Totale 4.600